OBJECTIVES: To describe the clinical and urodynamic features of @entity1 with @entity409 secondary to @entity13890 . @entity2040 mansoni is an @entity281 in South America, the Caribbean, and Africa. In the United States and Europe, @entity1 may be infected mainly through travel to endemic areas and immigration of infected individuals. Clinical involvement of the spinal cord is a well-recognized complication of the disease. The typical manifestations are those of an @entity5697 , with sudden onset of @entity16 associated with @entity1494 . METHODS: We reviewed the records and urodynamic studies of 14 consecutive @entity1 (10 @entity1 and 4 @entity1 , age range 23 to 49 years) with @entity13890 confirmed by cerebrospinal fluid serology for @entity383 , who were referred for evaluation of @entity409 during a 2-year period. At the time of the urologic evaluation, 9 @entity1 had chronic neurologic and urinary symptoms and 5 had recent onset of acute symptoms. The voiding function history, urologic complications, and outcomes after therapy for @entity2040 were reviewed. RESULTS: Of the @entity1 with @entity697 (5 @entity1 ), the urologic symptoms included urinary retention (3 @entity1 ) and @entity322 (2 @entity1 ). Three of them had concurrent @entity615 and @entity51 . Urodynamic studies were performed in 3 @entity1 and revealed @entity1494 in 2 @entity1 and @entity427 in 1 @entity1 . The @entity1 were started on clean intermittent catheterization and received @entity2039 and @entity288 . Three @entity1 had complete resolution of their symptoms, one recovered normal voiding function but the @entity51 persisted, and one had no clinical improvement. All @entity1 with chronic @entity13890 presented with @entity51 of varying degrees and urinary symptoms, including difficulty emptying the bladder (7 @entity1 ), @entity322 (6 @entity1 ), and urgency and frequency (2 @entity1 ). Laboratory and radiographic evaluation of @entity1 with chronic disease revealed @entity293 in 5 @entity1 , @entity3041 in 2 @entity1 , and @entity3226 in 2 @entity1 . Urologic management consisted of antibiotics, clean intermittent catheterization, anticholinergic medication, and stone removal, as appropriate. In 1 @entity1 , conservative treatment failed and that @entity1 required ileocystoplasty. CONCLUSIONS: @entity13890 is a potential cause of severe @entity409 secondary to @entity602 . A high index of suspicion is paramount because early medical intervention can abort the progression of @entity16 .

XXXX : urologic manifestations and urodynamic findings.

@entity1 :: ('9606', 'Species') :: ['men', 'patient', 'women', 'patients', 'people'] @entity5697 :: ('MESH:D009188', 'Disease') :: ['acute transverse myelitis'] @entity697 :: ('MESH:D000208', 'Disease') :: ['acute disease'] @entity322 :: ('MESH:D014549', 'Disease') :: ['urinary incontinence', 'incontinence'] @entity3226 :: ('MESH:D001744', 'Disease') :: ['bladder calculi'] @entity1494 :: ('MESH:D001745', 'Disease') :: ['bladder and bowel dysfunction', 'bladder areflexia'] @entity16 :: ('MESH:D009422', 'Disease') :: ['neurologic deterioration', 'lower extremity neuropathy'] @entity409 :: ('MESH:D008107', 'Disease') :: ['voiding dysfunction'] @entity602 :: ('MESH:D013118', 'Disease') :: ['spinal cord disease'] @entity3041 :: ('MESH:D006869', 'Disease') :: ['hydronephrosis'] @entity383 :: ('99802', 'Species') :: ['S. mansoni'] @entity281 :: ('MESH:D007239', 'Disease') :: ['endemic fluke infection'] @entity615 :: ('MESH:D001416', 'Disease') :: ['lower back pain'] @entity13890 :: ('MESH:D020818', 'Disease') :: ['Schistosomal myelopathy', 'schistosomal myelopathy'] @entity51 :: ('MESH:D009461', 'Disease') :: ['neurologic deficits', 'lower limb neurologic deficits'] @entity2040 :: ('MESH:D012552', 'Disease') :: ['Schistosomiasis', 'schistosomiasis'] @entity427 :: ('MESH:D012021', 'Disease') :: ['detrusor hyperreflexia with external sphincter dyssynergia'] @entity293 :: ('MESH:D014552', 'Disease') :: ['urinary tract infection'] @entity2039 :: ('MESH:D011223', 'Chemical') :: ['praziquantel'] @entity288 :: ('MESH:D000305', 'Chemical') :: ['corticosteroids']
@entity13890 :: (MESH:D020818,Disease) :: ['Schistosomal myelopathy']
